Arm A Mylotarg plus DA Versus CPX-351
AML18
Phase 3 small_molecule active
Quick answer
Arm A Mylotarg plus DA Versus CPX-351 for Acute Myeloid Leukaemia is a Phase 3 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Acute Myeloid Leukaemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active